Show simple item record

dc.contributor.authorKhonsari, F
dc.contributor.authorZakeri-Milani, P
dc.contributor.authorJelvehgari, M
dc.date.accessioned2018-08-26T08:55:40Z
dc.date.available2018-08-26T08:55:40Z
dc.date.issued2014
dc.identifier.urihttp://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/54336
dc.description.abstractThe present study involves preparation and evaluation of gastric-mucoadhesive microparticles with Metformin Hydrochloride as model drug for prolongation of gastric residence time. The microparticles were prepared by the emulsification solvent evaporation technique using polymers of Carbomer 934p (CP) and Ethylcellulose (EC). The microparticles were prepared by emulsion solvent evaporation method (O1/O2). Disc formulations were prepared by direct compression technique from microparticles. In the current study, gastric-mucoadhesive microparticles with different polymers ratios (CP:EC) were prepared and were characterized by encapsulation efficiency, particle size, flowability, mucoadhesive property and drug release studies. The best polymers ratio was 1:3 (F2) with Carbomer 934p (as mucoadhesive polymer) and ethylcellulose (as retardant polymer), respectively. The production yield microparticles F2 showed 98.80%, mean particle size 933.25 ?m and loading efficiency %98.44. The results were found that microparticle discs prepared had slower release than microparticles (p > o.o5). The microparticles exhibited very good percentage of mucoadhesion and flowability properties. The release of drug was prolonged to 8 h (71.65-82.22%) when incorporated into mucoadhesive microparticles. The poor bioavailability of metformine is attributed to short retention of its dosage form at the absorption sites (in upper gastrointestinal tract). The results of mucoadhesion study showed better retention of metformine microparticles (8 h) in duodenal and jejunum regions of intestine (F1, 1:2 ratio of CP:EC). Therefore, it may be concluded that drug loaded gastric-mucoadhesive microparticles are a suitable delivery system for metformin hydrochloride, and may be used for effective management of NIDDM (Non Insulin Dependent Diabetes Mellitus). آ© 2014 by School of Pharmacy Shaheed Beheshti University of Medical Sciences and Health Services.
dc.language.isoEnglish
dc.relation.ispartofIranian Journal of Pharmaceutical Research
dc.subjectcarbomer
dc.subjectethyl cellulose
dc.subjectgastric mucoadhesive microparticle
dc.subjectmetformin
dc.subjectnanomaterial
dc.subjectunclassified drug
dc.subjectanalytic method
dc.subjectangle of repose
dc.subjectanimal tissue
dc.subjectarticle
dc.subjectbioavailability
dc.subjectcarrs index
dc.subjectcontent uniformity
dc.subjectdifferential scanning calorimetry
dc.subjectdirect compression technique
dc.subjectdrug delivery system
dc.subjectdrug entrapment
dc.subjectdrug release
dc.subjectdrug solubility
dc.subjectemulsion solvent evaporation method
dc.subjectencapsulation efficiency
dc.subjectflow kinetics
dc.subjectHausner ratio
dc.subjecthistopathology
dc.subjectmucoadhesion
dc.subjectnonhuman
dc.subjectparticle size
dc.subjectpH
dc.subjectphysical chemistry
dc.subjectrat
dc.subjectstomach emptying
dc.subjectswelling study
dc.titleFormulation and evaluation of in-vitro characterization of gastic- mucoadhesive microparticles/discs containing metformin hydrochloride
dc.typeArticle
dc.citation.volume13
dc.citation.issue1
dc.citation.spage67
dc.citation.epage80
dc.citation.indexScopus


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record